Knockdown of lactate dehydrogenase by adeno‐associated virus‐delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1
Abstract Background Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder caused by endogenous overproduction of hepatic oxalate, leading to hyperoxaluria, recurrent calcium oxalate kidney stones, and end‐stage renal disease. Lactate dehydrogenase (LDH) is an ideal target for diminishing oxa...
Main Authors: | Rui Zheng, Xiaoliang Fang, Xi Chen, Yunteng Huang, Guofeng Xu, Lei He, Yueyan Li, Xuran Niu, Lei Yang, Liren Wang, Dali Li, Hongquan Geng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.261 |
Similar Items
-
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
by: Gema Ariceta, et al.
Published: (2021-04-01) -
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias
by: Maria Dolores Moya-Garzon, et al.
Published: (2021-01-01) -
Efficiency of using Canephron® N in the treatment of children with secondary hyperoxaluria
by: T.P. Borysova
Published: (2017-10-01) -
Unusual cause of renal failure in infancy: Primary hyperoxaluria
by: Kanchan Channawar, et al.
Published: (2015-01-01) -
Clinical and genetic profile of Indian children with primary hyperoxaluria
by: A Pinapala, et al.
Published: (2017-01-01)